Dermapharm Holding SE (DMP) - Total Liabilities

Latest as of March 2026: €1.54 Billion EUR ≈ $1.80 Billion USD

Based on the latest financial reports, Dermapharm Holding SE (DMP) has total liabilities worth €1.54 Billion EUR (≈ $1.80 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Dermapharm Holding SE growing its equity to track the company's year-over-year net asset growth rate.

Dermapharm Holding SE - Total Liabilities Trend (2013–2025)

This chart illustrates how Dermapharm Holding SE's total liabilities have evolved over time, based on quarterly financial data. See DMP free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Dermapharm Holding SE Competitors by Total Liabilities

The table below lists competitors of Dermapharm Holding SE ranked by their total liabilities.

Company	Country	Total Liabilities
Liontown Resources Limited F:LIS	Germany	€982.97 Million
Select Energy Services Inc NYSE:WTTR	USA	$587.24 Million
BGI Genomics Co Ltd SHE:300676	China	CN¥2.81 Billion
HUISHANG BK CORP. H YC1 F:HB8	Germany	€2.09 Trillion
Uniti Group Inc NASDAQ:UNIT	USA	$12.79 Billion
Hand Enterprise Solutions Co SHE:300170	China	CN¥1.08 Billion
Jointo Energy Investment Co Ltd Hebei SHE:000600	China	CN¥27.65 Billion
Shanghai Huayi Group Corp Ltd A SHG:600623	China	CN¥40.79 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Dermapharm Holding SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Dermapharm Holding SE (DMP) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.00	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.08	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dermapharm Holding SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dermapharm Holding SE (2013–2025)

The table below shows the annual total liabilities of Dermapharm Holding SE from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€1.50 Billion ≈ $1.76 Billion	+2.12%
2024-12-31	€1.47 Billion ≈ $1.72 Billion	-8.91%
2023-12-31	€1.62 Billion ≈ $1.89 Billion	+83.52%
2022-12-31	€880.34 Million ≈ $1.03 Billion	-2.95%
2021-12-31	€907.13 Million ≈ $1.06 Billion	+0.81%
2020-12-31	€899.81 Million ≈ $1.05 Billion	+18.34%
2019-12-31	€760.38 Million ≈ $888.97 Million	+69.54%
2018-12-31	€448.50 Million ≈ $524.34 Million	+31.29%
2017-12-31	€341.62 Million ≈ $399.39 Million	+36.16%
2016-12-31	€250.89 Million ≈ $293.32 Million	-0.53%
2015-12-31	€252.22 Million ≈ $294.88 Million	-14.96%
2014-12-31	€296.59 Million ≈ $346.74 Million	-3.90%
2013-12-31	€308.62 Million ≈ $360.80 Million	--

About Dermapharm Holding SE

XETRA:DMP Germany Drug Manufacturers - Specialty & Generic

Market Cap

$2.42 Billion

€2.07 Billion EUR

Market Cap Rank

#5646 Global

#896 in Germany

Share Price

€41.80

Change (1 day)

-2.45%

52-Week Range

€32.05 - €51.80

All Time High

€80.48